Install
Stay informed on the latest biopharmaceutical news, trends, and developments in Asia Pacific with BioPharma APAC. BioPharma Asia ( APAC ) provides in-depth analysis, insights, and expert commentary on drug development, regulatory updates, and industry partnerships in the region.
- 60articles · 30d
- 10+ hour agolatest article
- Aug 15, 2026earliest in window
- 97%with images
- 212avg words
- Medical 45
- Health & Wellness 36
- Economy, Business & Finance 23
- Health 20
- Business & Industrial 19
- Science & Technology 17
- Science & Nature 7
- Finance & Business 6
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Exegenesis Bio, Modalis Partner to Advance CRISPR-Based DMD Therapy MDL-201
10+ hour, 11+ min ago (68+ words) 14 September 2026 | Monday | News The financial impact of this research collaboration on Modalis' results for the current fiscal year is expected to be immaterial, and there is no revision to the earnings forecast at this time. Two Chairs, 11,000 Kilometres Apart: The…...
BGI Genomics Unveils Digital Life Twin Framework for Predictive Health Management
3+ day, 10+ hour ago (75+ words) 11 September 2026 | Friday | News Anchored by the Life Index system and built on precise risk stratification and systematic health assessments, this model connects upstream to BGI Genomics' full portfolio of multi-omics tests and interventions while empowering downstream healthcare providers and health…...
Convergen Raises $15M Seed+ to Accelerate Targeted Protein Degradation Therapies
1+ week, 5+ day ago (60+ words) 02 September 2026 | Wednesday | News The proceeds will be used to further advance Convergen's proprietary degrader platform and accelerate its pipeline for neurodegenerative disorders and other protein aggregation diseases. Two Chairs, 11,000 Kilometres Apart: The Human Cost of Asia’s Plasma Dependence China Plus…...
Data4Life, Monash Health Partner to Accelerate Clinical Trials and Real-World Evidence Generation
1+ week, 6+ day ago (180+ words) 01 September 2026 | Tuesday | News Data4Life and Monash Health have partnered to optimize clinical trial design and execution, complemented by educational workshops and professional training programs, with a shared commitment to improving patient outcomes. The Global Relations Office is a new site launched…...
Thermo Fisher Strengthens China Focus as Biopharma Innovation Gains Global Momentum
1+ week, 6+ day ago (344+ words) 01 September 2026 | Tuesday | News Thermo Fisher Scientific is reinforcing its commitment to China as the country emerges as an increasingly important source of global biopharmaceutical innovation, with Chairman and CEO Marc Casper highlighting opportunities to support Chinese drug developers across discovery,…...
DualityBio, Genentech Ink $1B-Plus Deal to Develop Next-Generation ADCs Against Drug-Resistant Tumours
2+ week, 10+ hour ago (234+ words) 31 August 2026 | Monday | News DUALITYBIO Inc. announced that it has entered into a collaboration and license agreement with Genentech, a member of the Roche Group, to develop next-generation antibody-drug conjugates ("ADCs") built on the Company's proprietary DualityBio Unique Payload Antibody Conjugate…...
Formosa Pharmaceuticals Files European CTA for TSY-110, Potential First Kadcyla Biosimilar in Regulated Markets
2+ week, 4+ hour ago (86+ words) 31 August 2026 | Monday | News Designed following regulatory guidance from both US and EU authorities, the upcoming trial will evaluate the safety, tolerability, pharmacokinetics, and immunogenicity profile of TSY-110 compared with the reference product. This milestone advances Formosa Pharmaceuticals' and EirGenix's shared…...
ASTRI, Saint Francis University Partner to Advance AI-Enabled Biomaterials and Digital Health
2+ week, 5+ day ago (215+ words) 26 August 2026 | Wednesday | News Ir Dr Ted Suen, Chief Executive Officer of ASTRI (left) and Professor Stephen Cheung Yan-leung, President of Saint Francis University (right), sign a Memorandum of Understanding today (24 August) establishing a strategic partnership to advance research and development…...
WuXi XDC H1 2026 Revenue Jumps 37% to RMB 3.7 Bn on Strong Bioconjugate Demand
2+ week, 5+ day ago (180+ words) 26 August 2026 | Wednesday | Company results WuXi XDC Cayman Inc. (the "WuXi XDC" or the "Group", stock code: 2268.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO) focused on the bioconjugate market, is pleased to announce its interim results for…...
Biocon Partners with Innomar Strategies to Strengthen Canada Supply Chain
2+ week, 6+ day ago (142+ words) 24 August 2026 | Monday | News Biocon has partnered with Innomar Strategies, a healthcare services and logistics company, to strengthen its pharmaceutical supply chain and distribution network across Canada. Under the collaboration, Innomar Strategies will serve as Biocon’s exclusive third-party logistics (3PL) provider in…...